Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 15, 2013

Poll Update: Whole Foods and GMO Labeling

  • Yesterday, we posted the poll below asking GEN readers how they feel about Whole Foods Market’s recent decision to require its supplier partners to label products containing GMO ingredients by 2018. As of 9:40 AM EST this morning, out of 195 voters so far since 12 AM EST yesterday, 112 (57.4%) answered the question, “Is Whole Foods Market doing the right thing by requiring labeling of all its genetically modified food products?” with “Yes” and 83 (42.6%) answered “No.” The number of votes just keeps on climbing, which tells us YOU—yes, YOU, GEN reader!—have something important to say about the issue.

    So, what DO you have to say? Do you agree with the results? Why not tell us by submitting a comment down below in the Readers’ Comments section? And, if you haven’t taken the poll yet, why not take it right now?

    Is Whole Foods Market doing the right thing by requiring labeling of all its genetically modified food products?



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »